background although sever therapeutic option become avail patient cuban cell lymphoma ctrl therapy cur recent studi demons cell overexpress cc chemin receptor ccr methodologyprincip find studi xenograft model establish recombin adenoassoci viral serotyp aaa vector express human singlechain variable fragment scfvfc fusion minibodi antics monoclonal antibody mab h value treatment human tumorbear mouse treat intranet infos vision encode aah show antitumor active vivo increase survive notable number tumorinfiltr log fcÎ³riiiacda marin neutrophil tumor xenograft aavcontrol furthermore correct infos periphery blood mononuclear pmc mark infiltr cda cd nk observe also induce vitro acc mouse conclusionssignific overall data demons media least part immune effector cell meghan until aavminibodi gene transfer system rapid value candid mab potent potent novel 